InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: PPHMVERYLONG post# 113423

Sunday, 01/31/2016 3:53:47 PM

Sunday, January 31, 2016 3:53:47 PM

Post# of 346172

Independent verification, that is the only thing that will move this stock forward. I have said it many times and it should be clear to anyone since the last two press releases did nothing.
Stop talking about "we are in talks", just sign a licensing deal and be done with it. The longer this goes on without a deal, the more obvious it is that what we have here may not be worth much.
Also, I think it is time to stop trying to predict how well a trial is going based on the fact that we have not heard results yet. How well did that work with the pancreatic trial? One word, terribly. For years we have been told, potential partners want to see interim phase II results, then more complete phase II results.
Well,we have that. They are running out of excuses. Then they will run out of money or be forced to finance to the detriment of current shareholders which we are used to.



PPHMVERYLONG, didn't you see the results in February of 2016 for that independent verification ? Oops, it is not Feb 2016 yet, lets revisit that at the end of the Feb, which begins tomorrow : )

As for making deals, Peregrine has made some superb ones and the public ones were with MSK, AZ and NCCN. Maybe some other non-public deals are awaiting certain events to happen ?

I do find it interesting at the arrival time of August 2012 and so much concentration put back on the pancreatic trial....hmmmm, who knows, maybe CSM in Fargo ND had some part of that as well

As for "they will run out of money.." Nope, they will not run out of money but will build a fortune in PS Targeting, licensing revenues IMO : )

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News